Alnylam Pharmaceuticals, Inc.
9 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Browse all held record sources
Zoom to read. Drag to explore. Select a connection.
Every link on this map
The same connections as a table, with the reason each one is here.
| HR 1672 | Bills it lobbied on | Alnylam Pharmaceuticals, Inc. named HR 1672, “Maintaining Investments in New Innovation Act”, in 25 lobbying reports. | 25 reports |
| HR 946 | Bills it lobbied on | Alnylam Pharmaceuticals, Inc. named HR 946, “ORPHAN Cures Act”, in 18 lobbying reports. | 18 reports |
| S 1862 | Bills it lobbied on | Alnylam Pharmaceuticals, Inc. named S 1862, “ORPHAN Cures Act”, in 11 lobbying reports. | 11 reports |
| HR 4993 | Bills it lobbied on | Alnylam Pharmaceuticals, Inc. named HR 4993, “Joe Fiandra Access to Home Infusion Act of 2025”, in 6 lobbying reports. | 6 reports |
| Brian Fitzpatrick | Lawmakers it funded or lobbied | Brian Fitzpatrick leads 1 bill Alnylam Pharmaceuticals, Inc. lobbied on. | Leads 1 of these bills |
| Donald Davis | Lawmakers it funded or lobbied | Donald Davis leads 1 bill Alnylam Pharmaceuticals, Inc. lobbied on. | Leads 1 of these bills |
| John Barrasso | Lawmakers it funded or lobbied | John Barrasso leads 1 bill Alnylam Pharmaceuticals, Inc. lobbied on. | Leads 1 of these bills |
| John Joyce | Lawmakers it funded or lobbied | John Joyce leads 1 bill Alnylam Pharmaceuticals, Inc. lobbied on. | Leads 1 of these bills |
| Alnylam Pharmaceuticals, Inc. | Source records | Alnylam Pharmaceuticals, Inc. has an explicit source reference to Alnylam Pharmaceuticals, Inc.. | None |
In the news
Reporting about the selected subject. Articles are context and do not establish a connection on this map.
Loading coverage…